Contract Manufacturing

Any company that serves the pharma industry on a contract basis to provide services from drug development through manufacturing. Content in this section will discuss the increasingly vital role of outsourcers such as CMOs, CDMOS, and CROS in pharma’s supply chain.

Articles

INCOG Biopharma: Pedaling towards excellence

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

Cellares: A disruptive impact on cell therapy

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

ten23 health: Sustainable success

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Raising a modern pharma CDMO

Four young companies built with intention tackle the future of medicine
Shutterstock 1664112631
Shutterstock 1664112631
Shutterstock 1664112631
Shutterstock 1664112631
Shutterstock 1664112631

Meeting biopharma’s infrastructure demands

Biopharma facilities must address the specific needs and concerns of this dynamic sector
Pm22 Hero 854x480 Act1 Cover Story
Pm22 Hero 854x480 Act1 Cover Story
Pm22 Hero 854x480 Act1 Cover Story
Pm22 Hero 854x480 Act1 Cover Story
Pm22 Hero 854x480 Act1 Cover Story

The great reappearing act: ADCs' triumphant return

In our three-part series, we cover the trajectory of cancer-fighting ADCs in the pharma industry, including the modality’s history, obstacles and success stories
Microsoft Teams Image (1)
Microsoft Teams Image (1)
Microsoft Teams Image (1)
Microsoft Teams Image (1)
Microsoft Teams Image (1)

The great reappearing act: ADCs light up the stage

In the third and final part of our series on antibody-drug conjugates, we discuss the recent market buzz and the rise of new conjugated modalities.
Shutterstock 736454596
Shutterstock 736454596
Shutterstock 736454596
Shutterstock 736454596
Shutterstock 736454596

CDMO growth strategies

Success is often rooted in a well-nourished plan
Pm2302 Hero 854x480 Cover Story
Pm2302 Hero 854x480 Cover Story
Pm2302 Hero 854x480 Cover Story
Pm2302 Hero 854x480 Cover Story
Pm2302 Hero 854x480 Cover Story

Pharma CDMOs built to thrive

When it comes to growth, how do you find just the right strategy for sustained success?
Pm23 Hero 854x480 Bora
Pm23 Hero 854x480 Bora
Pm23 Hero 854x480 Bora
Pm23 Hero 854x480 Bora
Pm23 Hero 854x480 Bora

CDMO Profile Series: Race to the top

Bora Pharmaceuticals’ quick rise has lifted drug manufacturing in Taiwan to new heights
PM2208-HERO-575x327-CoverStory
PM2208-HERO-575x327-CoverStory
PM2208-HERO-575x327-CoverStory
PM2208-HERO-575x327-CoverStory
PM2208-HERO-575x327-CoverStory

The radiopharma vision — and the next-gen companies seeing it through

Modern radiopharmaceutical companies are stacked with experienced experts who are laser-focused on correcting the missteps and misfortunes of earlier pioneers
PM2202-HERO-575x327-CoverStory3
PM2202-HERO-575x327-CoverStory3
PM2202-HERO-575x327-CoverStory3
PM2202-HERO-575x327-CoverStory3
PM2202-HERO-575x327-CoverStory3

Sterling Pharma Solutions: Paving a better way

How one CDMO's dedication to technology is making a global impact
Pushing-health-boundaries
Pushing-health-boundaries
Pushing-health-boundaries
Pushing-health-boundaries
Pushing-health-boundaries

Pushing health boundaries in space and manufacturing

CDMOs that ‘boldly go’ are helping propel the pharma industry forward
Feb-engineering
Feb-engineering
Feb-engineering
Feb-engineering
Feb-engineering

Achieving the ‘design one, build many’ paradigm

How diversity and digitization can help fast-track CDMO projects
PM2202-HERO-575x327-CoverStory1
PM2202-HERO-575x327-CoverStory1
PM2202-HERO-575x327-CoverStory1
PM2202-HERO-575x327-CoverStory1
PM2202-HERO-575x327-CoverStory1

Emergent BioSolutions: The path to re-emergence

How the Bayview plant put itself — and pandemic preparedness — on a better course